From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA panel backs Amgen's cholesterol-lowering drug

from The Wall Street Journal

A Food and Drug Administration advisory committee recommended that the agency approve Amgen Inc.’s cholesterol-lowering drug Repatha, the second in a class of promising heart medicines that could change medical practice and generate billions of dollars in sales. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063